Please use this identifier to cite or link to this item:
https://hdl.handle.net/2445/160218Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Palomer Tarridas, Francesc Xavier | - |
| dc.contributor.author | Pizarro Delgado, Javier | - |
| dc.contributor.author | Barroso Fernández, Emma | - |
| dc.contributor.author | Vázquez Carrera, Manuel | - |
| dc.date.accessioned | 2020-05-14T08:55:38Z | - |
| dc.date.available | 2020-05-14T08:55:38Z | - |
| dc.date.issued | 2018-03-01 | - |
| dc.identifier.issn | 1043-2760 | - |
| dc.identifier.uri | https://hdl.handle.net/2445/160218 | - |
| dc.description.abstract | Increased plasma non-esterified fatty acids (NEFAs) link obesity with insulin resistance and type 2 diabetes mellitus (T2DM). However, in contrast to the saturated FA (SFA) palmitic acid, the monounsaturated FA (MUFA) oleic acid elicits beneficial effects on insulin sensitivity, and the dietary palmitic acid:oleic acid ratio impacts diabetes risk in humans. Here we review recent mechanistic insights into the beneficial effects of oleic acid compared with palmitic acid on insulin resistance and T2DM, including its anti-inflammatory actions, and its capacity to inhibit endoplasmic reticulum (ER) stress, prevent attenuation of the insulin signaling pathway, and improve β cell survival. Understanding the molecular mechanisms of the antidiabetic effects of oleic acid may contribute to understanding the benefits of this FA in the prevention or delay of T2DM. | - |
| dc.format.extent | 13 p. | - |
| dc.format.mimetype | application/pdf | - |
| dc.language.iso | eng | - |
| dc.publisher | Elsevier Current Trends | - |
| dc.relation.isformatof | Versió postprint del document publicat a: https://doi.org/10.1016/j.tem.2017.11.009 | - |
| dc.relation.ispartof | Trends in Endocrinology and Metabolism, 2018, vol. 29, num. 3, p. 178-190 | - |
| dc.relation.uri | https://doi.org/10.1016/j.tem.2017.11.009 | - |
| dc.rights | cc-by-nc-nd (c) Elsevier Current Trends, 2018 | - |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/es | - |
| dc.source | Articles publicats en revistes (Farmacologia, Toxicologia i Química Terapèutica) | - |
| dc.subject.classification | Àcid oleic | - |
| dc.subject.classification | Resistència a la insulina | - |
| dc.subject.classification | Inflamació | - |
| dc.subject.classification | Diabetis no-insulinodependent | - |
| dc.subject.classification | Obesitat | - |
| dc.subject.other | Oleic acid | - |
| dc.subject.other | Insulin resistance | - |
| dc.subject.other | Inflammation | - |
| dc.subject.other | Non-insulin-dependent diabetes | - |
| dc.subject.other | Obesity | - |
| dc.title | Palmitic and oleic acid: The Yin and Yang of fatty acids in type 2 diabetes mellitus | - |
| dc.type | info:eu-repo/semantics/article | - |
| dc.type | info:eu-repo/semantics/acceptedVersion | - |
| dc.identifier.idgrec | 676383 | - |
| dc.date.updated | 2020-05-14T08:55:38Z | - |
| dc.rights.accessRights | info:eu-repo/semantics/openAccess | - |
| Appears in Collections: | Articles publicats en revistes (Farmacologia, Toxicologia i Química Terapèutica) | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| 676383.pdf | 3.29 MB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License
